Compare AMCI & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMCI | ORMP |
|---|---|---|
| Founded | 2021 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.4M | 141.3M |
| IPO Year | N/A | 2010 |
| Metric | AMCI | ORMP |
|---|---|---|
| Price | $5.11 | $4.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 41.3K | ★ 158.2K |
| Earning Date | 04-20-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 1.50 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $33.37 | ★ $3.13 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $3.60 | $1.98 |
| 52 Week High | $15.75 | $5.01 |
| Indicator | AMCI | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 35.53 | 69.57 |
| Support Level | $5.07 | $3.21 |
| Resistance Level | $7.20 | N/A |
| Average True Range (ATR) | 0.44 | 0.22 |
| MACD | -0.16 | 0.07 |
| Stochastic Oscillator | 11.64 | 68.64 |
AMC Robotics Corp is a technology solutions company that offers AI-powered smart security and robotics solutions. It currently sells smart hardware products designed for residential and commercial use, including smart cameras, driving recorders, action cameras, and Retina K cameras, which are marketed under the YI brand. AMC Robotics is also engaged in developing additional hardware products and technology capabilities, including IoT-enabled devices, AI-based features, wearable devices, and AI robotics. Using its technological capabilities, the company is developing robotic dogs, robotic arms, and robotic unloading systems, offering smart solutions for the logistics and warehousing sectors. It has two primary operating segments: North America, which generates maximum revenue, and Europe.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.